Vivos Therapeutics, Inc.

VVOS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$3,087$4,402$2,342$6,260
Short-Term Investments$0$0$0$0
Receivables$2,134$1,633$718$430
Inventory$0$0$0$0
Other Curr. Assets$565$695$547$783
Total Curr. Assets$5,786$6,730$3,607$7,473
Property Plant & Equip (Net)$9,025$8,373$4,259$4,382
Goodwill$8,450$8,450$2,843$2,843
Intangibles$2,172$2,225$358$370
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$211$255$215$216
Total NC Assets$19,858$19,303$7,675$7,811
Other Assets$0$0$0$0
Total Assets$25,644$26,033$11,282$15,284
Liabilities
Payables$2,103$1,763$1,206$1,098
Short-Term Debt$1,128$157$0$0
Tax Payable$0$0$0$481
Deferred Revenue$0$480$572$896
Other Curr. Liab.$4,206$2,084$672$273
Total Curr. Liab.$7,437$6,426$4,701$4,978
LT Debt$2,991$7,760$0$0
Deferred Rev, NC$0$5$22$97
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$12,684$4,304$1,220$1,220
Total NC Liab.$15,675$15,024$2,174$2,352
Other Liabilities$0$0$0$0
Cap. Leases$3,780$3,664$1,399$1,512
Total Liabilities$23,112$21,450$6,875$7,330
Equity
Pref Stock$0$0$0$0
Common Stock$1$0$0$0
Retained Earnings-$118,464-$113,064-$108,051-$104,187
AOCI$0$0$0$0
Other Equity$120,995$0$0$0
Total Equity$2,532$4,583$4,407$7,954
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$25,644$26,033$11,282$15,284
Net Debt$1,032$3,515-$2,342-$6,260
Vivos Therapeutics, Inc. (VVOS) Financial Statements & Key Stats | AlphaPilot